Additional PET/CT in week 5–6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
To access this article, please choose from the options below
PII: S0167-8140(08)00243-0
doi:10.1016/j.radonc.2008.05.004
© 2008 Elsevier Ireland Ltd. All rights reserved.
